Global Bio Similars/Subsequent Entry Biologic Market Growth (Status and Outlook) 2022-2028

Global Bio Similars/Subsequent Entry Biologic Market Growth (Status and Outlook) 2022-2028

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Bio Similars/Subsequent Entry Biologic Market Size 2017-2028
2.1.2 Bio Similars/Subsequent Entry Biologic Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Bio Similars/Subsequent Entry Biologic Segment by Type
2.2.1 Monoclonal Antibodies
2.2.2 Interferon
2.2.3 Erythropoietin
2.2.4 Insulin
2.2.5 Vaccines
2.2.6 Other
2.3 Bio Similars/Subsequent Entry Biologic Market Size by Type
2.3.1 Bio Similars/Subsequent Entry Biologic Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Bio Similars/Subsequent Entry Biologic Market Size Market Share by Type (2017-2022)
2.4 Bio Similars/Subsequent Entry Biologic Segment by Application
2.4.1 Tumor
2.4.2 Diabetes
2.4.3 Cardiovascular
2.4.4 Hemophilia
2.4.5 Other
2.5 Bio Similars/Subsequent Entry Biologic Market Size by Application
2.5.1 Bio Similars/Subsequent Entry Biologic Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Bio Similars/Subsequent Entry Biologic Market Size Market Share by Application (2017-2022)
3 Bio Similars/Subsequent Entry Biologic Market Size by Player
3.1 Bio Similars/Subsequent Entry Biologic Market Size Market Share by Players
3.1.1 Global Bio Similars/Subsequent Entry Biologic Revenue by Players (2020-2022)
3.1.2 Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Players (2020-2022)
3.2 Global Bio Similars/Subsequent Entry Biologic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Bio Similars/Subsequent Entry Biologic by Regions
4.1 Bio Similars/Subsequent Entry Biologic Market Size by Regions (2017-2022)
4.2 Americas Bio Similars/Subsequent Entry Biologic Market Size Growth (2017-2022)
4.3 APAC Bio Similars/Subsequent Entry Biologic Market Size Growth (2017-2022)
4.4 Europe Bio Similars/Subsequent Entry Biologic Market Size Growth (2017-2022)
4.5 Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size Growth (2017-2022)
5 Americas
5.1 Americas Bio Similars/Subsequent Entry Biologic Market Size by Country (2017-2022)
5.2 Americas Bio Similars/Subsequent Entry Biologic Market Size by Type (2017-2022)
5.3 Americas Bio Similars/Subsequent Entry Biologic Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bio Similars/Subsequent Entry Biologic Market Size by Region (2017-2022)
6.2 APAC Bio Similars/Subsequent Entry Biologic Market Size by Type (2017-2022)
6.3 APAC Bio Similars/Subsequent Entry Biologic Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Bio Similars/Subsequent Entry Biologic by Country (2017-2022)
7.2 Europe Bio Similars/Subsequent Entry Biologic Market Size by Type (2017-2022)
7.3 Europe Bio Similars/Subsequent Entry Biologic Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Bio Similars/Subsequent Entry Biologic by Region (2017-2022)
8.2 Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Type (2017-2022)
8.3 Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Bio Similars/Subsequent Entry Biologic Market Forecast
10.1 Global Bio Similars/Subsequent Entry Biologic Forecast by Regions (2023-2028)
10.1.1 Global Bio Similars/Subsequent Entry Biologic Forecast by Regions (2023-2028)
10.1.2 Americas Bio Similars/Subsequent Entry Biologic Forecast
10.1.3 APAC Bio Similars/Subsequent Entry Biologic Forecast
10.1.4 Europe Bio Similars/Subsequent Entry Biologic Forecast
10.1.5 Middle East & Africa Bio Similars/Subsequent Entry Biologic Forecast
10.2 Americas Bio Similars/Subsequent Entry Biologic Forecast by Country (2023-2028)
10.2.1 United States Bio Similars/Subsequent Entry Biologic Market Forecast
10.2.2 Canada Bio Similars/Subsequent Entry Biologic Market Forecast
10.2.3 Mexico Bio Similars/Subsequent Entry Biologic Market Forecast
10.2.4 Brazil Bio Similars/Subsequent Entry Biologic Market Forecast
10.3 APAC Bio Similars/Subsequent Entry Biologic Forecast by Region (2023-2028)
10.3.1 China Bio Similars/Subsequent Entry Biologic Market Forecast
10.3.2 Japan Bio Similars/Subsequent Entry Biologic Market Forecast
10.3.3 Korea Bio Similars/Subsequent Entry Biologic Market Forecast
10.3.4 Southeast Asia Bio Similars/Subsequent Entry Biologic Market Forecast
10.3.5 India Bio Similars/Subsequent Entry Biologic Market Forecast
10.3.6 Australia Bio Similars/Subsequent Entry Biologic Market Forecast
10.4 Europe Bio Similars/Subsequent Entry Biologic Forecast by Country (2023-2028)
10.4.1 Germany Bio Similars/Subsequent Entry Biologic Market Forecast
10.4.2 France Bio Similars/Subsequent Entry Biologic Market Forecast
10.4.3 UK Bio Similars/Subsequent Entry Biologic Market Forecast
10.4.4 Italy Bio Similars/Subsequent Entry Biologic Market Forecast
10.4.5 Russia Bio Similars/Subsequent Entry Biologic Market Forecast
10.5 Middle East & Africa Bio Similars/Subsequent Entry Biologic Forecast by Region (2023-2028)
10.5.1 Egypt Bio Similars/Subsequent Entry Biologic Market Forecast
10.5.2 South Africa Bio Similars/Subsequent Entry Biologic Market Forecast
10.5.3 Israel Bio Similars/Subsequent Entry Biologic Market Forecast
10.5.4 Turkey Bio Similars/Subsequent Entry Biologic Market Forecast
10.5.5 GCC Countries Bio Similars/Subsequent Entry Biologic Market Forecast
10.6 Global Bio Similars/Subsequent Entry Biologic Forecast by Type (2023-2028)
10.7 Global Bio Similars/Subsequent Entry Biologic Forecast by Application (2023-2028)

11 Key Players Analysis
11.1 Sun Pharma
11.1.1 Sun Pharma Company Information
11.1.2 Sun Pharma Bio Similars/Subsequent Entry Biologic Product Offered
11.1.3 Sun Pharma Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Sun Pharma Main Business Overview
11.1.5 Sun Pharma Latest Developments
11.2 Synthon Pharmaceuticals
11.2.1 Synthon Pharmaceuticals Company Information
11.2.2 Synthon Pharmaceuticals Bio Similars/Subsequent Entry Biologic Product Offered
11.2.3 Synthon Pharmaceuticals Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Synthon Pharmaceuticals Main Business Overview
11.2.5 Synthon Pharmaceuticals Latest Developments
11.3 Teva Pharmaceutical Industries
11.3.1 Teva Pharmaceutical Industries Company Information
11.3.2 Teva Pharmaceutical Industries Bio Similars/Subsequent Entry Biologic Product Offered
11.3.3 Teva Pharmaceutical Industries Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Teva Pharmaceutical Industries Main Business Overview
11.3.5 Teva Pharmaceutical Industries Latest Developments
11.4 LG Life Sciences
11.4.1 LG Life Sciences Company Information
11.4.2 LG Life Sciences Bio Similars/Subsequent Entry Biologic Product Offered
11.4.3 LG Life Sciences Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 LG Life Sciences Main Business Overview
11.4.5 LG Life Sciences Latest Developments
11.5 Celltrion Biocon
11.5.1 Celltrion Biocon Company Information
11.5.2 Celltrion Biocon Bio Similars/Subsequent Entry Biologic Product Offered
11.5.3 Celltrion Biocon Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Celltrion Biocon Main Business Overview
11.5.5 Celltrion Biocon Latest Developments
11.6 Hospira
11.6.1 Hospira Company Information
11.6.2 Hospira Bio Similars/Subsequent Entry Biologic Product Offered
11.6.3 Hospira Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Hospira Main Business Overview
11.6.5 Hospira Latest Developments
11.7 Merck
11.7.1 Merck Company Information
11.7.2 Merck Bio Similars/Subsequent Entry Biologic Product Offered
11.7.3 Merck Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Merck Main Business Overview
11.7.5 Merck Latest Developments
11.8 Biogen idec
11.8.1 Biogen idec Company Information
11.8.2 Biogen idec Bio Similars/Subsequent Entry Biologic Product Offered
11.8.3 Biogen idec Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Biogen idec Main Business Overview
11.8.5 Biogen idec Latest Developments
11.9 Genentech (Roche)
11.9.1 Genentech (Roche) Company Information
11.9.2 Genentech (Roche) Bio Similars/Subsequent Entry Biologic Product Offered
11.9.3 Genentech (Roche) Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Genentech (Roche) Main Business Overview
11.9.5 Genentech (Roche) Latest Developments
11.10 Pfizer
11.10.1 Pfizer Company Information
11.10.2 Pfizer Bio Similars/Subsequent Entry Biologic Product Offered
11.10.3 Pfizer Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Pfizer Main Business Overview
11.10.5 Pfizer Latest Developments
11.11 Celltrion
11.11.1 Celltrion Company Information
11.11.2 Celltrion Bio Similars/Subsequent Entry Biologic Product Offered
11.11.3 Celltrion Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Celltrion Main Business Overview
11.11.5 Celltrion Latest Developments
11.12 Biocon
11.12.1 Biocon Company Information
11.12.2 Biocon Bio Similars/Subsequent Entry Biologic Product Offered
11.12.3 Biocon Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Biocon Main Business Overview
11.12.5 Biocon Latest Developments
11.13 Amgen
11.13.1 Amgen Company Information
11.13.2 Amgen Bio Similars/Subsequent Entry Biologic Product Offered
11.13.3 Amgen Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Amgen Main Business Overview
11.13.5 Amgen Latest Developments
11.14 Samsung Biologics
11.14.1 Samsung Biologics Company Information
11.14.2 Samsung Biologics Bio Similars/Subsequent Entry Biologic Product Offered
11.14.3 Samsung Biologics Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Samsung Biologics Main Business Overview
11.14.5 Samsung Biologics Latest Developments
11.15 Mylan
11.15.1 Mylan Company Information
11.15.2 Mylan Bio Similars/Subsequent Entry Biologic Product Offered
11.15.3 Mylan Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Mylan Main Business Overview
11.15.5 Mylan Latest Developments
11.16 Dr. Reddy's Laboratories
11.16.1 Dr. Reddy's Laboratories Company Information
11.16.2 Dr. Reddy's Laboratories Bio Similars/Subsequent Entry Biologic Product Offered
11.16.3 Dr. Reddy's Laboratories Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Dr. Reddy's Laboratories Main Business Overview
11.16.5 Dr. Reddy's Laboratories Latest Developments
11.17 Stada Arzneimittel AG
11.17.1 Stada Arzneimittel AG Company Information
11.17.2 Stada Arzneimittel AG Bio Similars/Subsequent Entry Biologic Product Offered
11.17.3 Stada Arzneimittel AG Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Stada Arzneimittel AG Main Business Overview
11.17.5 Stada Arzneimittel AG Latest Developments
11.18 AbbVie
11.18.1 AbbVie Company Information
11.18.2 AbbVie Bio Similars/Subsequent Entry Biologic Product Offered
11.18.3 AbbVie Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 AbbVie Main Business Overview
11.18.5 AbbVie Latest Developments
11.19 Sanofi-Aventis
11.19.1 Sanofi-Aventis Company Information
11.19.2 Sanofi-Aventis Bio Similars/Subsequent Entry Biologic Product Offered
11.19.3 Sanofi-Aventis Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 Sanofi-Aventis Main Business Overview
11.19.5 Sanofi-Aventis Latest Developments
11.20 Johnson & Johnson
11.20.1 Johnson & Johnson Company Information
11.20.2 Johnson & Johnson Bio Similars/Subsequent Entry Biologic Product Offered
11.20.3 Johnson & Johnson Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.20.4 Johnson & Johnson Main Business Overview
11.20.5 Johnson & Johnson Latest Developments
11.21 Novo Nordisk
11.21.1 Novo Nordisk Company Information
11.21.2 Novo Nordisk Bio Similars/Subsequent Entry Biologic Product Offered
11.21.3 Novo Nordisk Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.21.4 Novo Nordisk Main Business Overview
11.21.5 Novo Nordisk Latest Developments
11.22 Eli Lilly
11.22.1 Eli Lilly Company Information
11.22.2 Eli Lilly Bio Similars/Subsequent Entry Biologic Product Offered
11.22.3 Eli Lilly Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.22.4 Eli Lilly Main Business Overview
11.22.5 Eli Lilly Latest Developments
11.23 Novartis
11.23.1 Novartis Company Information
11.23.2 Novartis Bio Similars/Subsequent Entry Biologic Product Offered
11.23.3 Novartis Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.23.4 Novartis Main Business Overview
11.23.5 Novartis Latest Developments
11.24 3sbio
11.24.1 3sbio Company Information
11.24.2 3sbio Bio Similars/Subsequent Entry Biologic Product Offered
11.24.3 3sbio Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.24.4 3sbio Main Business Overview
11.24.5 3sbio Latest Developments
11.25 Biotech
11.25.1 Biotech Company Information
11.25.2 Biotech Bio Similars/Subsequent Entry Biologic Product Offered
11.25.3 Biotech Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.25.4 Biotech Main Business Overview
11.25.5 Biotech Latest Developments
11.26 Gelgen
11.26.1 Gelgen Company Information
11.26.2 Gelgen Bio Similars/Subsequent Entry Biologic Product Offered
11.26.3 Gelgen Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.26.4 Gelgen Main Business Overview
11.26.5 Gelgen Latest Developments
11.27 Innovent
11.27.1 Innovent Company Information
11.27.2 Innovent Bio Similars/Subsequent Entry Biologic Product Offered
11.27.3 Innovent Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.27.4 Innovent Main Business Overview
11.27.5 Innovent Latest Developments
11.28 Dong Bao
11.28.1 Dong Bao Company Information
11.28.2 Dong Bao Bio Similars/Subsequent Entry Biologic Product Offered
11.28.3 Dong Bao Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.28.4 Dong Bao Main Business Overview
11.28.5 Dong Bao Latest Developments
11.29 Ganlee
11.29.1 Ganlee Company Information
11.29.2 Ganlee Bio Similars/Subsequent Entry Biologic Product Offered
11.29.3 Ganlee Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2020-2022)
11.29.4 Ganlee Main Business Overview
11.29.5 Ganlee Latest Developments
12 Research Findings and Conclusion

List of Tables
Table 1. Bio Similars/Subsequent Entry Biologic Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Monoclonal Antibodies
Table 3. Major Players of Interferon
Table 4. Major Players of Erythropoietin
Table 5. Major Players of Insulin
Table 6. Major Players of Vaccines
Table 7. Major Players of Other
Table 8. Bio Similars/Subsequent Entry Biologic Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Bio Similars/Subsequent Entry Biologic Market Size by Type (2017-2022) & ($ Millions)
Table 10. Global Bio Similars/Subsequent Entry Biologic Market Size Market Share by Type (2017-2022)
Table 11. Bio Similars/Subsequent Entry Biologic Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 12. Global Bio Similars/Subsequent Entry Biologic Market Size by Application (2017-2022) & ($ Millions)
Table 13. Global Bio Similars/Subsequent Entry Biologic Market Size Market Share by Application (2017-2022)
Table 14. Global Bio Similars/Subsequent Entry Biologic Revenue by Players (2020-2022) & ($ Millions)
Table 15. Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Player (2020-2022)
Table 16. Bio Similars/Subsequent Entry Biologic Key Players Head office and Products Offered
Table 17. Bio Similars/Subsequent Entry Biologic Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Bio Similars/Subsequent Entry Biologic Market Size by Regions 2017-2022 & ($ Millions)
Table 21. Global Bio Similars/Subsequent Entry Biologic Market Size Market Share by Regions (2017-2022)
Table 22. Americas Bio Similars/Subsequent Entry Biologic Market Size by Country (2017-2022) & ($ Millions)
Table 23. Americas Bio Similars/Subsequent Entry Biologic Market Size Market Share by Country (2017-2022)
Table 24. Americas Bio Similars/Subsequent Entry Biologic Market Size by Type (2017-2022) & ($ Millions)
Table 25. Americas Bio Similars/Subsequent Entry Biologic Market Size Market Share by Type (2017-2022)
Table 26. Americas Bio Similars/Subsequent Entry Biologic Market Size by Application (2017-2022) & ($ Millions)
Table 27. Americas Bio Similars/Subsequent Entry Biologic Market Size Market Share by Application (2017-2022)
Table 28. APAC Bio Similars/Subsequent Entry Biologic Market Size by Region (2017-2022) & ($ Millions)
Table 29. APAC Bio Similars/Subsequent Entry Biologic Market Size Market Share by Region (2017-2022)
Table 30. APAC Bio Similars/Subsequent Entry Biologic Market Size by Type (2017-2022) & ($ Millions)
Table 31. APAC Bio Similars/Subsequent Entry Biologic Market Size Market Share by Type (2017-2022)
Table 32. APAC Bio Similars/Subsequent Entry Biologic Market Size by Application (2017-2022) & ($ Millions)
Table 33. APAC Bio Similars/Subsequent Entry Biologic Market Size Market Share by Application (2017-2022)
Table 34. Europe Bio Similars/Subsequent Entry Biologic Market Size by Country (2017-2022) & ($ Millions)
Table 35. Europe Bio Similars/Subsequent Entry Biologic Market Size Market Share by Country (2017-2022)
Table 36. Europe Bio Similars/Subsequent Entry Biologic Market Size by Type (2017-2022) & ($ Millions)
Table 37. Europe Bio Similars/Subsequent Entry Biologic Market Size Market Share by Type (2017-2022)
Table 38. Europe Bio Similars/Subsequent Entry Biologic Market Size by Application (2017-2022) & ($ Millions)
Table 39. Europe Bio Similars/Subsequent Entry Biologic Market Size Market Share by Application (2017-2022)
Table 40. Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Region (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size Market Share by Region (2017-2022)
Table 42. Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Type (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size Market Share by Type (2017-2022)
Table 44. Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Application (2017-2022) & ($ Millions)
Table 45. Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size Market Share by Application (2017-2022)
Table 46. Key Market Drivers & Growth Opportunities of Bio Similars/Subsequent Entry Biologic
Table 47. Key Market Challenges & Risks of Bio Similars/Subsequent Entry Biologic
Table 48. Key Industry Trends of Bio Similars/Subsequent Entry Biologic
Table 49. Global Bio Similars/Subsequent Entry Biologic Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 50. Global Bio Similars/Subsequent Entry Biologic Market Size Market Share Forecast by Regions (2023-2028)
Table 51. Global Bio Similars/Subsequent Entry Biologic Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 52. Global Bio Similars/Subsequent Entry Biologic Market Size Market Share Forecast by Type (2023-2028)
Table 53. Global Bio Similars/Subsequent Entry Biologic Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 54. Global Bio Similars/Subsequent Entry Biologic Market Size Market Share Forecast by Application (2023-2028)
Table 55. Sun Pharma Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 56. Sun Pharma Bio Similars/Subsequent Entry Biologic Product Offered
Table 57. Sun Pharma Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 58. Sun Pharma Main Business
Table 59. Sun Pharma Latest Developments
Table 60. Synthon Pharmaceuticals Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 61. Synthon Pharmaceuticals Bio Similars/Subsequent Entry Biologic Product Offered
Table 62. Synthon Pharmaceuticals Main Business
Table 63. Synthon Pharmaceuticals Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 64. Synthon Pharmaceuticals Latest Developments
Table 65. Teva Pharmaceutical Industries Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 66. Teva Pharmaceutical Industries Bio Similars/Subsequent Entry Biologic Product Offered
Table 67. Teva Pharmaceutical Industries Main Business
Table 68. Teva Pharmaceutical Industries Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 69. Teva Pharmaceutical Industries Latest Developments
Table 70. LG Life Sciences Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 71. LG Life Sciences Bio Similars/Subsequent Entry Biologic Product Offered
Table 72. LG Life Sciences Main Business
Table 73. LG Life Sciences Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 74. LG Life Sciences Latest Developments
Table 75. Celltrion Biocon Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 76. Celltrion Biocon Bio Similars/Subsequent Entry Biologic Product Offered
Table 77. Celltrion Biocon Main Business
Table 78. Celltrion Biocon Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 79. Celltrion Biocon Latest Developments
Table 80. Hospira Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 81. Hospira Bio Similars/Subsequent Entry Biologic Product Offered
Table 82. Hospira Main Business
Table 83. Hospira Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 84. Hospira Latest Developments
Table 85. Merck Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 86. Merck Bio Similars/Subsequent Entry Biologic Product Offered
Table 87. Merck Main Business
Table 88. Merck Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 89. Merck Latest Developments
Table 90. Biogen idec Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 91. Biogen idec Bio Similars/Subsequent Entry Biologic Product Offered
Table 92. Biogen idec Main Business
Table 93. Biogen idec Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 94. Biogen idec Latest Developments
Table 95. Genentech (Roche) Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 96. Genentech (Roche) Bio Similars/Subsequent Entry Biologic Product Offered
Table 97. Genentech (Roche) Main Business
Table 98. Genentech (Roche) Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 99. Genentech (Roche) Latest Developments
Table 100. Pfizer Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 101. Pfizer Bio Similars/Subsequent Entry Biologic Product Offered
Table 102. Pfizer Main Business
Table 103. Pfizer Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. Pfizer Latest Developments
Table 105. Celltrion Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 106. Celltrion Bio Similars/Subsequent Entry Biologic Product Offered
Table 107. Celltrion Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 108. Celltrion Main Business
Table 109. Celltrion Latest Developments
Table 110. Biocon Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 111. Biocon Bio Similars/Subsequent Entry Biologic Product Offered
Table 112. Biocon Main Business
Table 113. Biocon Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 114. Biocon Latest Developments
Table 115. Amgen Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 116. Amgen Bio Similars/Subsequent Entry Biologic Product Offered
Table 117. Amgen Main Business
Table 118. Amgen Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 119. Amgen Latest Developments
Table 120. Samsung Biologics Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 121. Samsung Biologics Bio Similars/Subsequent Entry Biologic Product Offered
Table 122. Samsung Biologics Main Business
Table 123. Samsung Biologics Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 124. Samsung Biologics Latest Developments
Table 125. Mylan Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 126. Mylan Bio Similars/Subsequent Entry Biologic Product Offered
Table 127. Mylan Main Business
Table 128. Mylan Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 129. Mylan Latest Developments
Table 130. Dr. Reddy's Laboratories Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 131. Dr. Reddy's Laboratories Bio Similars/Subsequent Entry Biologic Product Offered
Table 132. Dr. Reddy's Laboratories Main Business
Table 133. Dr. Reddy's Laboratories Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 134. Dr. Reddy's Laboratories Latest Developments
Table 135. Stada Arzneimittel AG Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 136. Stada Arzneimittel AG Bio Similars/Subsequent Entry Biologic Product Offered
Table 137. Stada Arzneimittel AG Main Business
Table 138. Stada Arzneimittel AG Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 139. Stada Arzneimittel AG Latest Developments
Table 140. AbbVie Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 141. AbbVie Bio Similars/Subsequent Entry Biologic Product Offered
Table 142. AbbVie Main Business
Table 143. AbbVie Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 144. AbbVie Latest Developments
Table 145. Sanofi-Aventis Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 146. Sanofi-Aventis Bio Similars/Subsequent Entry Biologic Product Offered
Table 147. Sanofi-Aventis Main Business
Table 148. Sanofi-Aventis Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 149. Sanofi-Aventis Latest Developments
Table 150. Johnson & Johnson Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 151. Johnson & Johnson Bio Similars/Subsequent Entry Biologic Product Offered
Table 152. Johnson & Johnson Main Business
Table 153. Johnson & Johnson Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 154. Johnson & Johnson Latest Developments
Table 155. Novo Nordisk Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 156. Novo Nordisk Bio Similars/Subsequent Entry Biologic Product Offered
Table 157. Novo Nordisk Bio Similars/Subsequent Entry Biologic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 158. Novo Nordisk Main Business
Table 159. Novo Nordisk Latest Developments
Table 160. Eli Lilly Details, Company Type, Bio Similars/Subsequent Entry Biologic Area Served and Its Competitors
Table 161. Eli Lilly Bi

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs